Systematic review of the roles of interleukins in hepatocellular carcinoma
- 4 March 2020
- journal article
- review article
- Published by Elsevier BV in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 506, 33-43
- https://doi.org/10.1016/j.cca.2020.03.001
Abstract
No abstract availableKeywords
This publication has 105 references indexed in Scilit:
- Improving immunotherapy of hepatocellular carcinoma (HCC) using dendritic cells (DC) engineered to express IL‐12 in vivoLiver International, 2013
- High expression of IL-17 and IL-17RE associate with poor prognosis of hepatocellular carcinomaJournal of Experimental & Clinical Cancer Research, 2013
- Interleukin 23 Promotes Hepatocellular Carcinoma Metastasis via NF-Kappa B Induced Matrix Metalloproteinase 9 ExpressionPLOS ONE, 2012
- Co-transfection of dendritic cells with AFP and IL-2 genes enhances the induction of tumor antigen-specific antitumor immunityExperimental and Therapeutic Medicine, 2012
- IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinomaMolecular Cancer, 2011
- Interleukin 17A Promotes Hepatocellular Carcinoma Metastasis via NF-kB Induced Matrix Metalloproteinases 2 and 9 ExpressionPLOS ONE, 2011
- Prognostic value of interleukin 2 and interleukin 15 in peritumoral hepatic tissues for patients with hepatitis B-related hepatocellular carcinoma after curative resectionGut, 2010
- Intratumoral Neoadjuvant Immunotherapy Using IL-12 and Dendritic Cells Is an Effective Strategy To Control Recurrence of Murine Hepatocellular Carcinoma in Immunosuppressed MiceThe Journal of Immunology, 2010
- Treatment of Hepatocellular Carcinoma with Adeno-Associated Virus Encoding Interleukin-15 SuperagonistHuman Gene Therapy, 2010
- Interleukin-17F Suppresses Hepatocarcinoma Cell Growth via Inhibition of Tumor AngiogenesisCancer Investigation, 2009